The federal government’s proposed drug testing trial for selected unemployment benefits claimants has been greeted with depressingly predictable objections from the usual suspects. The two year trial commencing in 2018 will target approximately five thousand Newstart recipients. Individuals testing positive will trigger a range of outcomes including a limiting of the amount of welfare available to them as cash, repeat drug testing, and/or referral to a clinician for a treatment activity.